The CXCL4 level is elevated in the blood and skin of SSc patients [79], in correlation with the presence and progression of complications such as ILD and pulmonary arterial hypertension (PAH) [79, 91]. The gene discussed is PF4; the disease is pulmonary arterial hypertension.